COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

COVID-induced neuroinflammation can last 2 years or longer, according to new PET data
These findings are important to consider with regard to patients’ long-term health, as chronic inflammation has been implicated in cognitive decline.
Why all heart patients should be vaccinated against the flu, COVID-19, RSV
The American College of Cardiology has shared new recommendations highlighting the protective benefits of a variety of vaccines. The new guidance also examines how to speak with patients who are hesitant to be vaccinated.
Florida looks to end all vaccine mandates, including those deemed routine
In a press conference held by Gov. Ron DeSantis, Florida Surgeon General Joseph Ladapo, MD, PhD, condemned all compulsory vaccinations, declaring that the “body is a gift from God.”
Researcher Vinay Prasad returns to FDA after abrupt resignation
Prasad, MD, left the agency following a blog post from right-wing pundit Laura Loomer highlighting his progressive political views. However, now less than two weeks later, he returns to his leadership role in vaccine policy.
HHS ends support for mRNA vaccines in favor of ‘novel platforms’
Secretary of Health and Human Services Robert F. Kennedy Jr. says the agency is winding down support for mRNA as it looks to "whole virus" vaccines that offer broad protection against seasonal illnesses such as COVID-19 and influenza.

First drug found to improve COVID-19 survival

A commonly known steroid drug has been found to greatly improve survival for COVID-19 patients. In fact, among severe patients, the steroid, Dexamethasone, reduced the number of deaths by one-third in a study conducted by the University of Oxford.

FDA says hydroxychloroquine unlikely to be effective in treating COVID-19

The FDA has revoked its emergency use authorization for hydroxychloroquine as a treatment for COVID-19 hospital patients, determining that the controversial drug was “unlikely to be effective in treating COVID-19.”

New payment model could save rural hospitals from a post-COVID collapse

The COVID-19 pandemic hit rural hospitals especially hard—and that’s bad news for patients in areas already associated with poor cardiovascular outcomes.

Honoring the nearly 600 US healthcare workers who have died from COVID-19

As the COVID-19 pandemic rages on, it is difficult to know just how many healthcare workers have lost their lives battling this deadly virus. According to a new project, the number currently sits at 586—and it is expected to continue rising.

Racial, gender disparities among heart transplant recipients with COVID-19

The researchers explored data from orthotopic heart transplant patients who were hospitalized for COVID-19 at one of two facilities.

HHS will distribute another $35B in COVID-19 relief to healthcare companies

HHS is distributing another $35 billion from the CARES Act designated for healthcare providers responding to the crisis. The CARES Act allocated $175 billion in relief funds to hospitals and healthcare providers, especially those majorly affected by the pandemic.

Hypertension associated with greater risk of dying from COVID-19—but RAAS inhibitors can help

Hypertension is associated with a much greater risk of dying from COVID-19, according to new research published in European Heart Journal. The study’s authors noted that outcomes improved if patients took antihypertensive medications as recommended.

Hospital allegedly lied about COVID-19 patient’s death

The hospital is accused of listing an acute myocardial infarction as the cause of the patient’s death and not mentioning COVID-19 at all.

COVID-19

COVID-induced neuroinflammation can last 2 years or longer, according to new PET data

Why all heart patients should be vaccinated against the flu, COVID-19, RSV

Florida looks to end all vaccine mandates, including those deemed routine

Researcher Vinay Prasad returns to FDA after abrupt resignation

HHS ends support for mRNA vaccines in favor of ‘novel platforms’